AWM
TWST icon

AE Wealth Management’s Twist Bioscience TWST Stock Holding History

AE Wealth Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,280
Closed -$304K – 1715
2021
Q2 		$304K Buy
+2,280
New +$265K ﹤0.01% 1342

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AE Wealth Management's TWST Position: Q3 2021 in Review

AE Wealth Management sold out of Twist Bioscience (TWST) in Q3 2021, closing a stake of 2,280 shares — an estimated $304K sold.

AE Wealth Management first reported a position in TWST in Q2 2021 and held it in 1 quarter. The position peaked at $304K in Q2 2021. 235 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

  • AE Wealth Management reported no remaining Twist Bioscience position as of Q3 2021 after selling out during the quarter.
  • AE Wealth Management sold 2,280 Twist Bioscience shares in Q3 2021, an estimated $304K.
  • AE Wealth Management first reported a position in Twist Bioscience in Q2 2021 and held it in 1 quarter.
  • AE Wealth Management's Twist Bioscience position peaked at $304K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on AE Wealth Management's 13F filing for Q3 2021, filed 1 Nov 2021.